123 related articles for article (PubMed ID: 21868532)
1. K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.
Keohavong P; Kahkonen B; Kinchington E; Yin J; Jin J; Liu X; Siegfried JM; DI YP
Anticancer Res; 2011 Sep; 31(9):2877-82. PubMed ID: 21868532
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M
Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156
[TBL] [Abstract][Full Text] [Related]
3. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Kawano R; Takeshima Y; Inai K
Jpn J Cancer Res; 1996 Jan; 87(1):44-50. PubMed ID: 8609047
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
5. Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice.
Matzinger SA; Gunning WT; You M; Castonguay A
Mol Carcinog; 1994 Sep; 11(1):42-8. PubMed ID: 7916989
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
7. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.
Devereux TR; Anderson MW; Belinsky SA
Carcinogenesis; 1991 Feb; 12(2):299-303. PubMed ID: 1995195
[TBL] [Abstract][Full Text] [Related]
8. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.
Oreffo VI; Lin HW; Padmanabhan R; Witschi H
Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721
[TBL] [Abstract][Full Text] [Related]
9. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents.
Ronai ZA; Gradia S; Peterson LA; Hecht SS
Carcinogenesis; 1993 Nov; 14(11):2419-22. PubMed ID: 7902220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.
Yao R; Rioux N; Castonguay A; You M
Exp Lung Res; 2000 Dec; 26(8):731-42. PubMed ID: 11195467
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy.
Liu CH; Chen Z; Chen K; Liao FT; Chung CE; Liu X; Lin YC; Keohavong P; Leikauf GD; Di YP
Cancer Res; 2021 Jan; 81(1):144-157. PubMed ID: 33122306
[TBL] [Abstract][Full Text] [Related]
12. A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice.
Hollander MC; Zhou X; Maier CR; Patterson AD; Ding X; Dennis PA
Carcinogenesis; 2011 Aug; 32(8):1279-84. PubMed ID: 21625009
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains.
Devereux TR; Belinsky SA; Maronpot RR; White CM; Hegi ME; Patel AC; Foley JF; Greenwell A; Anderson MW
Mol Carcinog; 1993; 8(3):177-85. PubMed ID: 8216736
[TBL] [Abstract][Full Text] [Related]
14. RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents.
Qian X; Khammanivong A; Song JM; Teferi F; Upadhyaya P; Dickerson E; Kassie F
Inflamm Res; 2015 May; 64(5):343-61. PubMed ID: 25795230
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer.
Melkamu T; Qian X; Upadhyaya P; O'Sullivan MG; Kassie F
Vet Pathol; 2013 Sep; 50(5):895-902. PubMed ID: 23381924
[TBL] [Abstract][Full Text] [Related]
16. Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.
Hollander MC; Balogh AR; Liwanag J; Han W; Linnoila RI; Anver MR; Dennis PA
Neoplasia; 2008 Aug; 10(8):866-72. PubMed ID: 18683321
[TBL] [Abstract][Full Text] [Related]
17. Lung carcinomas induced by NNK and LPS.
Di ME; Kahkonen B; Liu CH; Di YP
Methods Cell Biol; 2021; 163():175-185. PubMed ID: 33785164
[TBL] [Abstract][Full Text] [Related]
18. Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.
Hisamoto A; Kondo E; Kiura K; Okada T; Hosokawa S; Mimoto J; Takigawa N; Tabata M; Tanimoto M
Lung Cancer; 2007 Oct; 58(1):15-20. PubMed ID: 17604873
[TBL] [Abstract][Full Text] [Related]
19. Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.
Murphy SE; von Weymarn LB; Schutten MM; Kassie F; Modiano JF
Cancer Prev Res (Phila); 2011 Nov; 4(11):1752-60. PubMed ID: 22027684
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA injury and the fixation of the DNA injury in mouse lungs.
Yano T; Yajima S; Nakamura T; Horikawa S; Kishimoto M; Ichikawa T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):275-8. PubMed ID: 9750015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
